AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06015581 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality Management, Mystery Shopper Feedback
Description: Mystery shoppers visit each agency two times per quarter to systematically examine testing clinics' environmental characteristics and their experiences with clinic staff (e.g., quality of testing session, safer sex discussions, perceived provider competency, PrEP discussions and referral). The investigator team meets with each agency once per quarter to review the data and provide technical assistance.
Study NCT06015581 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Quality Management, Mystery Shopper Feedback
Description: Mystery shoppers visit each agency two times per quarter to systematically examine testing clinics' environmental characteristics and their experiences with clinic staff (e.g., quality of testing session, safer sex discussions, perceived provider competency, PrEP discussions and referral). The investigator team meets with each agency once per quarter to review the data and provide technical assistance.
Study NCT04881136 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reveal LINQ™
Description: The physical device is the Reveal LINQ™, which is a small implantable loop recorder that is used to monitor cardiac parameters at present. The Investigational Falls Prediction RAMware is software that will be downloaded on to the Reveal LINQ™ that will enable it to collect additional sensor information including accelerometer and posture count data that will be used for gait analysis.
Study NCT05125133 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ITENs + ITWS
Description: A dual active ingredient (dual AI) Insecticide-Treated Eave nets (ITENs) in combination with Insecticide Treated Window screens (ITWS) for house modification.
Study NCT05968326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autogene cevumeran
Description: Autogene cevumeran will be administered intravenously (IV) at a recommended dose at specified timepoints.
Study NCT05968326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab will be administered IV at a dose of 1680 milligrams (mg) at specified timepoints.
Study NCT05968326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFIRINOX
Description: mFOLFIRINOX (oxaliplatin, leucovorin, irinotecan, 5-FU) will be administered IV at specified timepoints.
Study NCT05968326 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mFOLFIRINOX
Description: mFOLFIRINOX (oxaliplatin, leucovorin, irinotecan, 5-FU) will be administered IV at specified timepoints.
Study NCT05201638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMU-838 tablets
Description: Patients are randomized to IMU-838 or placebo in ratio 1:1
Study NCT05201638 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching IMU-838 tablets
Description: Patients are randomized to IMU-838 or placebo in ratio 1:1
Study NCT05592249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dual Task MC
Description: Dual Task MC group will receive 60 minutes motor - cognitive dual task intervention 5 day per week for 6 weeks in clinic.
Study NCT05592249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dual Task MM
Description: Dual Task MM group will receive 60 minutes motor - motor dual task intervention 5 day per week for 6 weeks in clinic.
Study NCT06083415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Environmental health measures
Description: MRI will be used to confirm the presence of breast buds, to measure the size of the ovaries and uterus, as well as the fraction of fat mass (abdominal, subcutaneous, liver and bone marrow). The bood and urine tests will allow to measure different biological and metabolic parameters. The presence of endocrine disruptors will be determined in the hair. The bone age x ray will be estimate the maturity of the child's skeletal system.
Study NCT05690815 — intervention group
Intervention type: DRUG
Intervention: Descovy
Description: Descovy is a once-daily prescription medicine for adults and adolescents at risk of HIV. It helps lower the chances of getting HIV through sex. In this study, patients at risk of acquiring HIV will be screened for HIV and those that are HIV-negative will be initiated on PrEP within 24 hours.
Study NCT04627831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CE-Iohexol
Description: Captisol-Enabled™ Iohexol as needed for the diagnostic procedure. Volume will be determined according to medical need.
Study NCT04627831 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iohexol
Description: Iohexol as needed for the diagnostic procedure. Volume will be determined according to medical need.
Study NCT05402306 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment group
Description: Group metacognitive therapy, mainly with attention training technique over two weeks.
Study NCT04894448 — intervention group
Intervention type: BIOLOGICAL
Intervention: COVID-19 Vaccine
Description: Any COVID-19 vaccine (1 or more doses)
Study NCT06327217 — intervention group
Intervention type: RADIATION
Intervention: Bilateral hip x-ray
Description: Patients will be asked to visit the clinic for a bilateral hip x-ray, in order to evaluate the degree os osteoarthritis.
Study NCT06327217 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Patients will be asked to complete questionnaires on function, quality of life and pain (the modified Harris Hip Score (mHHS), Hip Outcome Score (HOS), the World Health Organisation Quality of Life Questionnaire (WHOWOL) and Visual Analogue Scale (VAS) for pain). One question will be asked: 'How satisfied are you with the results of the surgery?' on a 10-point scale.
Study NCT06183450 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: auditory level
Description: * Evaluation of auditory thresholds through audiometric tests.~* Evaluation of speech comprehension in noise through a vocal audiometry test in noise (FraMatrix).~* Evaluation of spatial auditory behavior and spatial precision using a spatial discrimination test (Minimum Audible Angle) and a static sound localization test in virtual reality.
Study NCT06183450 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: cognitive level
Description: * Evaluation of attention and short-term memory functions with verbal and non-verbal tasks: Digit Span Test and Reading Span Test.~* Evaluation of inhibition capacities using the Stroop Test.~* Evaluation of executive functions, visual attention, reasoning, and mental arithmetic using the Raven's Matrix test.
Study NCT06183450 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: quality of life level
Description: - Evaluation of quality of live level via Speech, Spatial and Qualities of Hearing Scale (SSQ-12) and EuroQol-5D questionnaires.
Study NCT05678738 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Antioxidant Berry Supplementation
Description: Participants who opt-in will be instructed to consume 300mL of the bioactive (antioxidant berry) supplement every morning and afternoon during days of participation.
Study NCT05678738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acute and Chronic Exercise-Heat Stress
Description: All participants (male and female) will be exposed to repeated bouts of exercise-heat stress.
Study NCT05678738 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute and Chronic Exercise-Heat Stress
Description: All participants (male and female) will be exposed to repeated bouts of exercise-heat stress.
Study NCT05678738 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Acute and Chronic Exercise-Heat Stress
Description: All participants (male and female) will be exposed to repeated bouts of exercise-heat stress.
Study NCT05678738 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (non-juice) Supplementation
Description: Participants who opt-in will be instructed to consume 300mL of the placebo (non-juice) supplement every morning and afternoon during days of participation.
Study NCT06412887 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality headset
Description: Meta-Quest 2 virtual reality headset was used in this study
Study NCT06412887 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset
Description: Meta-Quest 2 virtual reality headset was used in this study
Study NCT04989361 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Soluble Hyaluronic Acid Microneedle
Description: The soluble hyaluronic acid microneedle eye mask is a nanometer-sized microneedle made of water-soluble hyaluronic acid, which can directly inject the active ingredients into the dermis, and after being absorbed and dissolved by the skin, it can achieve the purpose of improving the water content and elasticity of the skin.
Study NCT04989361 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-fractional laser
Description: he non-ablative fractional laser use 1565nm fiber laser, which acts on the target base in the dermis-water. The beam penetrates the epidermis and acts on the dermis. Using the principle of focal light and heat, the tissue cells are heated to initiate the repair process, which promotes increased collagen synthesis, thereby Achieve the effect of firming the skin and improving wrinkles.
Study NCT06205121 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OATD-01
Description: OATD-01 is an oral inhibitor of chitinase-1 (CHIT1)
Study NCT06205121 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo tablets
Study NCT05383261 — intervention group
Intervention type: OTHER
Intervention: exercise
Description: aerobic and resisted ex
Study NCT06018467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib 100 Mg Oral Tablet
Description: Dasatinib tablets in blister packs of 10 tablets, from either: Sandoz, STADA Nordic, Zentiva or Bristol-Myers Squibb
Study NCT06018467 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Quercetin 1.250 mg (oral)
Description: five 200mg Quercetin Phytosome capsules, from Thorne
Study NCT06018467 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide Riboside 1g (oral)
Description: four 250mg Nicotinamide Riboside Capsules, from Elysium Health
Study NCT05131477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KY1005
Description: Pharmaceutical form: Injection solution Route of administration: Subcutaneous
Study NCT05131477 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: Injection solution Route of administration: Subcutaneous
Study NCT04845620 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARQ-151 Active
Description: ARQ-151 Cream 0.05% - Active
Study NCT04845620 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ARQ-151 Vehicle
Description: ARQ-151 Cream - Vehicle
Study NCT06257498 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: MRI scan
Description: MRI scan on open scanner and some questionnaires
Study NCT05835752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAY1225
Description: Administered SC
Study NCT05835752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC
Study NCT04905537 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: It's only observational study. No interventions.
Study NCT05558449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hypnosedation
Description: Hypnosedation session with a virtual reality headset during the regional anesthesia technique and during the surgery (approximately 60 minutes). The VRH module used will be Silva, i.e. the same scenario of a walk in the forest through the 4 seasons with a voice accompanying the hypnosis session.
Study NCT05558449 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam injection
Description: Midazolam intravenous injection 1 mg until RASS -3
Study NCT05558449 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality
Description: Only virtual reality without a hypnosedation session. The virtual reality headset will be used on these patients without external voice or hypnosis device. The virtual reality module used will be Silva, i.e. a scenario of a walk in the forest through the 4 seasons.
Study NCT06175429 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Physical performance testing
Description: Assessment of physical performance using established clinical tests and scoring systems
Study NCT06175429 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Breath sampling and VOC analysis
Description: Sampling of exhaled breath and using Proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF) for VOC quantification.
Study NCT06175429 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Muscle ultrasound
Description: Quantitative and qualitative assessment of different limb skeletal muscles using non-invasive ultrasound.
Study NCT06175429 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood-based biomarker analysis
Description: Blood sampling and assessment of different blood-based biomarkers of muscle integrity using Enzyme-linked Immunosorbent Assay (ELISA) and Electrochemiluminescence Immunoassay (ECLIA)
Study NCT06516666 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music
Description: Participants went through four stages. In the rest stage, they were instructed to relax. In the neutral control stage, they watched an informative video about plastic injection molding. In the sadness induction stage, they viewed sad clips from either Hachi: A Dog's Tale or My Brother and Sister, with the order randomized across participants. In the music intervention stage, they listened to the cheerful Cuckoo Waltz. Each stage lasted for about 6 minutes.~The interventions for the two groups were exactly same.~PS: On the basis of the PHQ-9, this HAMD interview was conducted to further group the participants. So, following the experimental protocol, participants who scored ≥ 5 on the PHQ-9 measure underwent the HAMD interview, while the remaining individuals were simply interviewed about their feelings during the experiment.
Study NCT05390424 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood collection using Dried Blood Spot
Description: Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection
Study NCT04783532 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Mindfulness Program
Description: Enrolled participants will participate in an individual (one-on-one) Telehealth-delivered (online with audio and video) mindfulness intervention with a trained mindfulness therapist. The intervention is adapted from mindfulness-based cognitive therapy and includes eight sessions lasting 75 minutes each (except the first session which lasts 90 minutes) over a 3-month period.
Study NCT04743245 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TherOx DownStream System
Description: SSO2 Therapy with Therox downstream System after Percutaneous Coronary Intervention (PCI)
Study NCT04743245 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PCI
Description: Standard Care of PCI
Study NCT04743245 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PCI
Description: Standard Care of PCI
Study NCT04657016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC
Study NCT04657016 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study NCT04798963 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: On-clamp partial nephrectomy
Description: Partial nephrectomy will performed with renal artery clamping (less than or equal to 25 minutes)
Study NCT04962906 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gam-COVID-Vac / Gam-COVID-Vac
Description: A comparison of antibody levels against protein S will be performed using the Gam-COVID-Vac / Gam-COVID-Vac group as a control group and the Gam-COVID-Vac / ChAdOx1 nCoV-19 and Gam-COVID-Vac / BBIBP-CorV groups as comparators.
Study NCT05086198 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Description: An instructor trained in Mindfulness-based Stress Reduction (MBSR; Kabat-Zinn, 1990) will conduct meditations lasting 15 to 30 minutes. The participants will have a mobile application designed ad hoc with the practice of the week so they can do it individually at home.
Study NCT05086198 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical exercise
Description: An aerobic and fitness trainer will conduct aerobic exercise lasting 15 to 30 minutes. The participants will watch it in a video platform. They will not be able to do anaerobic exercise like weight lifting. The intensity of the chosen exercise will be moderate, maintaining between 120-140 beats per minute.
Study NCT06380166 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hepatitis C core antigen
Description: Semi-quantitative, automated immunoassay detecting core antigen of hepatitis C virus.
Study NCT04902612 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HM242-Solution
Description: HM242-Solution compared to Saline compared in patients with a venous leg ulcer
Study NCT04902612 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: HM242-Solution compared to Saline compared in patients with a venous leg ulcer
Study NCT06451588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FMT
Description: Active FMT
Study NCT06451588 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo treatment will be prepared based on the patients' fecal samples (autologous).
Study NCT05879757 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: As this is an observational study, no intervention will be administered in this study.
Study NCT06639789 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin B12 (B12)
Description: The new formulation of vitamin B12 will be ingested 3 days before and on the day of testing (3 hours before).
Study NCT06639789 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO (PLA)
Description: The placebo will be ingested 3 days before and the same day of the tests (3 hours before).
Study NCT06564805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candida Albicans Antigen Injection
Description: subcutaneous administration of Candida albicans antigen
Study NCT06564805 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Candida Albicans Antigen Injection
Description: subcutaneous administration of Candida albicans antigen
Study NCT06563947 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Oral enterobacterium capsules
Description: Enterobacterium capsules (300 mg/per capsule) orally 6 capsules/day for 10 consecutive days.
Study NCT05284643 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Proton Therapy (IMPT)
Description: Participants will receive radiation therapy delivered via intensity modulated proton therapy (IMPT) simultaneous integrated boost technique over a period of 10 days, 5 days per week for approximately 2 weeks.
Study NCT05284643 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab will be administered intravenously (IV), beginning at a dose of 10 mg/kg every 2-3 weeks until disease progression.
Study NCT05789251 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Standardized breakfast
Description: Standardized breakfast to replace in fine oral induced hyperglycemia test
Study NCT05523908 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High-dose hypofraction Arm
Description: Patients in this arm would receive high-dose fractionated radiotherapy with 60Gy/15f
Study NCT05523908 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low-dose hypofraction Arm (Standard BED)
Description: Patients in this arm would receive low-dose fractionated radiotherapy with 48Gy/12f
Study NCT05590663 — intervention group
Intervention type: OTHER
Intervention: Physiotherapy
Description: routine referral-based physiotherapy treatment for patients with knee osteoarthritis
Study NCT04747301 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Double-balloon catheter (UTAH CVX-RIPE) for cervical ripening
Description: Sweeping the membranes by UTAH CVX-RIPE® (Utah Medical Products, Inc, 7043 South 300 West, Midvale, Utah 84047 USA). The catheter will be inserted manually until the proximal balloon is in the cervical canal, the distal balloon should be intrauterine and in the extra-amniotic space. The intrauterine balloon is inflated with 40mL saline and retracted so that it rests against the internal oz. The proximal balloon should now be outside the external oz and is inflated with 20mL saline. If the balloons are correctly situated on both ends of the cervix, they can be inflated with up to 80mL saline each.~Cardiotocograph will be performed 30min, 2 hours after insertion and every 6 hours. The balloon is placed for a maximum of 24 hours.~If it is expelled in the first 12 hours and the patient has no contractions or still shows an unfavorable cervix, another balloon is placed for a maximum of another 24 hours.~The patients will be examined in case of extremely painful or membranes ruptured.